News
Premiums for ACA health plans, also known as Obamacare, which many early retirees and small-business owners rely on for coverage, are going up.
A giant Indian drugmaker failed to fix safety breaches. The FDA let it off the hook again and again.
For eight years, as inspectors returned and discovered again and again that Sun’s efforts were grossly inadequate, the FDA did little to warn the public or stop the drugs from coming to the U.S.
This year’s honorees will be revealed in December. They’ll be celebrated at an event on February 12, 2026, at NYC's Edison Ballroom.
The biopharma’s campaign for the treatment, which received FDA approval late last year to treat HS, aims to help patients get back to daily activities.
The FDA cautions the outcomes described in the complaints may have no connection to the drugs or could be unexpected side effects. Get to know each of these companies by learning about their culture, ...
The FDA cautions the outcomes described in the complaints may have no connection to the drugs or could be unexpected side effects.
LONDON: S4 Capital, the agency group led by Martin Sorrell, has confirmed that MSQ Partners, the owner of The Gate, approached it about a “possible combination.” S4 Capital said in a statement to the ...
Aaru will add to IPG’s Acxiom capabilities in identity resolution and audience management, aiming to predict which audiences are most qualified for acquisition, upselling, cross-selling and win-back, ...
Seles is going public with her experience as a patient living with myasthenia gravis in a partnership with Argenx.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results